×
About 3,944 results

ALLMedicine™ Anaplastic Large Cell Lymphoma Center

Research & Reviews  1,859 results

An effusion-based presentation of ALK- anaplastic large cell lymphoma.
https://doi.org/10.1182/blood.2021011140
Blood Zhao Y, Wang E

May 6th, 2021 - An effusion-based presentation of ALK- anaplastic large cell lymphoma.|2021|Zhao Y,Wang E,|

A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lym...
https://doi.org/10.1097/MD.0000000000025770 10.1097/PAS.0b0
Medicine Lyu WT, Song QB et. al.

May 5th, 2021 - CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior. The PC-ALCL with aggressive behavior has not been reported in the literature. We treated a pati...

Non-Malignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALC...
https://doi.org/10.1093/asj/sjab215
Aesthetic Surgery Journal; Kadin ME, Xu H et. al.

May 4th, 2021 - CD30 lymphocyte activation antigen and phosphorylated STAT3 (pSTAT3) are consistent markers of tumor cells in breast implant associated anaplastic large cell lymphoma (BIA-ALCL). We present a case of BIA-ALCL in a breast implant capsule containing...

Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are...
https://doi.org/10.1093/asj/sjab170
Aesthetic Surgery Journal; Reisman NR

May 3rd, 2021 - Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?|2021|Reisman NR,|

Primary and secondary central nervous system mature T- and NK-cell lymphomas.
https://doi.org/10.1053/j.seminhematol.2021.02.003
Seminars in Hematology; Pang Y, Chihara D

Apr 28th, 2021 - Primary central nervous system (CNS) mature T- and NK-cell lymphomas are rare, only comprising 2% to 3% of all primary CNS lymphomas. Among them, peripheral T-cell lymphoma, not otherwise specified, anaplastic large cell lymphoma (ALCL), and extra...

see more →

Guidelines  5 results

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anap...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106983
Journal of Clinical Oncology : Official Journal of the Am... Jaffe ES, Ashar BS et. al.

Feb 11th, 2020 - To provide guidelines for the accurate pathologic diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulecto...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers
https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm630863.htm
FDA

Feb 5th, 2019 - The Food and Drug Administration (FDA) wants to increase awareness about an association between all breast implants, regardless of filling or texture, and Breast Implant Associated- Anaplastic Large Cell Lymphoma (BIA-ALCL). The FDA received repor...

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S14/5304915
Oishi,N.,et al

Jan 30th, 2019 - Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a newly included provisional entity in the 2016 revision of the World Health Organization classification, is a distinct form of CD30-positive T-cell non-Hodgkin lymphoma that ari...

2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S3/5304919
Clemens,M.,et al

Jan 30th, 2019 - National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of the majority of known cancers. NCCN guidelines on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) ...

NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated...
https://doi.org/10.1093/asj/sjw259
Aesthetic Surgery Journal; Clemens MW, Horwitz SM

Feb 11th, 2017 - Published case series demonstrate a lack of treatment standardization for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with a wide variety of therapeutic strategies being employed at all stages of disease. The National Compr...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  1,977 results

An effusion-based presentation of ALK- anaplastic large cell lymphoma.
https://doi.org/10.1182/blood.2021011140
Blood Zhao Y, Wang E

May 6th, 2021 - An effusion-based presentation of ALK- anaplastic large cell lymphoma.|2021|Zhao Y,Wang E,|

A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lym...
https://doi.org/10.1097/MD.0000000000025770 10.1097/PAS.0b0
Medicine Lyu WT, Song QB et. al.

May 5th, 2021 - CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior. The PC-ALCL with aggressive behavior has not been reported in the literature. We treated a pati...

Non-Malignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALC...
https://doi.org/10.1093/asj/sjab215
Aesthetic Surgery Journal; Kadin ME, Xu H et. al.

May 4th, 2021 - CD30 lymphocyte activation antigen and phosphorylated STAT3 (pSTAT3) are consistent markers of tumor cells in breast implant associated anaplastic large cell lymphoma (BIA-ALCL). We present a case of BIA-ALCL in a breast implant capsule containing...

Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are...
https://doi.org/10.1093/asj/sjab170
Aesthetic Surgery Journal; Reisman NR

May 3rd, 2021 - Commentary on: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?|2021|Reisman NR,|

Primary and secondary central nervous system mature T- and NK-cell lymphomas.
https://doi.org/10.1053/j.seminhematol.2021.02.003
Seminars in Hematology; Pang Y, Chihara D

Apr 28th, 2021 - Primary central nervous system (CNS) mature T- and NK-cell lymphomas are rare, only comprising 2% to 3% of all primary CNS lymphomas. Among them, peripheral T-cell lymphoma, not otherwise specified, anaplastic large cell lymphoma (ALCL), and extra...

see more →

News  101 results

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.staging.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

Number of Cases of Breast Implant-linked Lymphoma in the UK
https://www.medscape.com/viewarticle/933637

Jul 8th, 2020 - As of April 2020, there have been 68 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reported in the UK. This figure includes cases where the original implantation did not occur in the UK. Based on the number of cases,...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers | FDA
https://www.fda.gov/medical-devices/letters-health-care-providers/breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl-letter-health-care-providers

The information in this letter has been superseded by The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Sa...

Breast Implant and Blood Cancer Advice Updated
https://www.medscape.com/viewarticle/899959

Aug 21st, 2019 - Health professionals have been reminded to continue to report suspected cases of breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) in patients who have had breast implants or who have had them removed. In an update to two previou...

see more →